Bottom line
Is EDEN a good fund? The bottom line
EDEN is an index international stock ETF from iShares.
Annual fees run 0.53% — about $53 a year on every $10,000 invested, cheaper than 82% of international stock funds we track.
It returned −3.8% over one year, +10.6% a year over five years, +10.2% a year over ten (as of Dec 31, 2024, per its prospectus).
With $203 million in net assets and 45 holdings, its largest position is Novo Nordisk A/s (21.4%) and the top 10 make up 68.2% of the portfolio.
What stands out
- Low cost: cheaper than 82% of international stock peers
- 5-year return beat 85% of category peers
What to watch
- Concentrated: top 10 holdings are 68.2% of assets
Updated Nov 19, 2026
What EDEN invests in
The iShares MSCI Denmark ETF (the Fund ) seeks to track the investment results of a broad-based index composed of Danish equities.
The Fund seeks to track the investment results of the MSCI Denmark IMI 25/50 Index (the Underlying Index ), which is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Denmark. The Underlying Index is rebalanced quarterly using an optimization process that aims to minimize the constituent weight differences between the Underlying Index and the MSCI Denmark Index (the Parent Index ). The Underlying Index uses a capping methodology that limits the weight of any single group entity (constituents that MSCI determines have a control relationship) to a maximum of 25% of the Underlying Index weight, and the sum of all group entities with a weight above 5% to an aggregate of 50% of the Underlying Index weight. A group entity is a group of companies that operate as…
From the fund's prospectus (filed Dec 19, 2025).
EDEN performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| EDEN | −3.8% | +10.6% | +10.2% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2024
What EDEN costs
On a $10,000 investment, EDEN's 0.53% expense ratio costs about $53 a year. The prospectus estimates $665 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
EDEN top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Novo Nordisk A/s | 21.36% |
| 2 | Dsv A/s | 11.19% |
| 3 | Danske Bank A/s | 7.67% |
| 4 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 5.25% |
| 5 | Vestas Wind Systems A/s | 5.17% |
| 6 | Novozymes A/s | 4.35% |
| 7 | Genmab A/s | 3.79% |
| 8 | Oersted A/S | 3.51% |
| 9 | Carlsberg A/s | 3.23% |
| 10 | A.p. Moeller - Maersk A/s | 2.62% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 68.2% of the fund. See all top 25 holdings and asset mix →